Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000224189 | SCV000280639 | likely benign | not provided | 2016-04-28 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Eurofins Ntd Llc |
RCV000597443 | SCV000702376 | benign | not specified | 2016-10-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000224189 | SCV001044858 | likely benign | not provided | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000224189 | SCV002002892 | uncertain significance | not provided | 2020-02-17 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV004658992 | SCV005162371 | likely benign | Inborn genetic diseases | 2024-06-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003947732 | SCV004776250 | likely benign | ARHGAP31-related disorder | 2019-03-04 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |